New weight loss drug gains US approval, sparks fierce competition
A new weight loss medication from <strong>Lilly</strong> has received approval from the <strong>U.S. Food and Drug Administration</strong>, paving the way for strong competition with <strong>Novo Nordisk</strong>. This development comes at a time when interest in obesity treatments is surging in the United States.